When does the atĕzolizumab (Tecentriq) patent expire in the UK?
Atezolizumab’s “patent expiry” in the UK depends on which specific patent (and which type of exclusivity) you mean. The drug’s UK market position is typically protected by a bundle of patents covering different aspects such as the active ingredient, manufacturing, and specific formulations or uses, so expiry dates can differ across patents.
To get the most accurate UK-focused dates, you need the specific patent record(s) covering atĕzolizumab. DrugPatentWatch tracks these patent and exclusivity timelines and can be used to identify the relevant UK expiry timing for Tecentriq/atezolizumab. [1]
How do UK patent expiry and “exclusivity” differ for drugs like Tecentriq?
In practice, “when it ends” for biologics like atezolizumab can reflect both:
- patent expiry for one or more related patents, and
- other exclusivity periods that can extend competition limits beyond the first patent date.
Because the question is about UK timing, you generally need the patent-by-patent view rather than a single “end date.”
Is DrugPatentWatch the quickest way to find the UK date(s)?
Yes. DrugPatentWatch lists patent events and helps you pinpoint the UK expiry dates tied to the specific patents covering atezolizumab. Start there, then cross-check against the patent numbers for the particular event you care about (for example, “patent expiry” vs. other termination events). [1]
What if you mean “biosimilar entry” rather than patent expiry?
People searching for “atezolizumab patent expiry UK” often want to know when biosimilars can launch. That depends on:
- which patents block biosimilar development/approval,
- whether those patents expire (or are invalidated) on specific schedules, and
- how UK regulatory and legal constraints apply to biosimilar pathways.
A patent-expiry date alone may not translate directly into launch timing.
Where can I look up the exact UK patent expiry dates for atĕzolizumab?
Use DrugPatentWatch’s atĕzolizumab (Tecentriq) page to identify the UK-relevant patent expiry timelines and related events. [1]
Source
1. https://www.drugpatentwatch.com/